Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Financial Services FeesIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest Expense - DebtInterest Expense - OthersInterest ExpensesInterest Income - NetInterest Income - TotalInterest income - InvestmentsNet Income towards Common StockholdersNon Operating Investment IncomeNon-Interest IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Trading IncomeWages, Salaries and Other
Others
Ratios

PhenixFIN (PFX) EBITDA (2016 - 2025)

Historic EBITDA for PhenixFIN (PFX) over the last 15 years, with Q4 2025 value amounting to $2.1 million.

  • PhenixFIN's EBITDA rose 3083.0% to $2.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.6 million, marking a year-over-year increase of 2131.04%. This contributed to the annual value of $5.1 million for FY2025, which is 858.62% up from last year.
  • As of Q4 2025, PhenixFIN's EBITDA stood at $2.1 million, which was up 3083.0% from $1.4 million recorded in Q3 2025.
  • PhenixFIN's 5-year EBITDA high stood at $5.4 million for Q2 2021, and its period low was $200111.0 during Q4 2021.
  • Over the past 5 years, PhenixFIN's median EBITDA value was $1.5 million (recorded in 2024), while the average stood at $1.6 million.
  • Within the past 5 years, the most significant YoY rise in PhenixFIN's EBITDA was 85497.87% (2021), while the steepest drop was 9759.76% (2021).
  • Quarter analysis of 5 years shows PhenixFIN's EBITDA stood at $200111.0 in 2021, then skyrocketed by 723.87% to $1.6 million in 2022, then rose by 3.65% to $1.7 million in 2023, then fell by 4.88% to $1.6 million in 2024, then skyrocketed by 30.83% to $2.1 million in 2025.
  • Its EBITDA stands at $2.1 million for Q4 2025, versus $1.4 million for Q3 2025 and $1.2 million for Q2 2025.